ClearPoint Neuro, Inc. products

The SmartFlow MR Compatible Ventricular Cannula has received 510(k) clearance from the FDA for use in the US for the aspiration of CSF, or injection of the chemotherapy drug Cytarabine into the ventricle. It has also been CE marked for use in Europe for the delivery of approved fluids into the brain or aspiration of CSF. It’s being utilized in approved clinical and preclinical studies for various research and drug trials. This device is not intended for implant and is intended for single patient use only.

The FDA-cleared and CE Marked ClearPoint Neuro Navigation System provides real-time MRI guidance for cannula placement. When combined with the SmartFlow® Cannula*, this can allow for assessment of infusion coverage and delivery of approved therapeutics to regions of interest in the brain in clinical trials.